Literature DB >> 15961703

Iron stores and vascular function in voluntary blood donors.

Haoyi Zheng1, Ritchard Cable, Bryan Spencer, Nancy Votto, Stuart D Katz.   

Abstract

BACKGROUND: Iron is a pro-oxidant cofactor that may be linked to atherosclerosis progression. Reduction of body iron stores secondary to blood donation has been hypothesized to reduce coronary risk, but retrospective studies have yielded inconsistent findings. We sought to assess the effects of blood donation frequency on body iron stores and physiological and biochemical biomarkers of vascular function associated with atherosclerosis progression. METHODS AND
RESULTS: Forty high-frequency voluntary blood donors (> or =8 donations in past 2 years) and 42 low-frequency blood donors (1 to 2 donations in past 2 years) aged 50 to 75 years were randomly selected from American Red Cross of Connecticut blood donor records. Flow-mediated dilation in the brachial artery, serum markers of iron stores, vascular inflammation and oxidative stress, and cardiac risk factors were assessed in all subjects. Serum ferritin was significantly decreased in high-frequency blood donors when compared with low-frequency blood donors (median values 17 versus 52 ng/mL; P<0.001), but hematocrit did not differ between groups. Flow-mediated dilation in the brachial artery was significantly greater in high-frequency donors when compared with low-frequency donors in univariate analysis (5.5+/-2.6% versus 3.8+/-1.6%; P=0.0003) and in multivariate analysis adjusting for cardiac risk factors and other potential confounders. Serum biomarkers of vascular inflammation did not differ between groups but 3-nitrotyrosine, a marker of oxidative stress, was decreased in high-frequency donors when compared with low-frequency donors.
CONCLUSIONS: High-frequency blood donors had evidence of decreased body iron stores, decreased oxidative stress, and enhanced vascular function when compared with low-frequency donors. These findings support a potential link between blood donation and reduced cardiovascular risk that warrants further investigation in prospective outcome studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961703     DOI: 10.1161/01.ATV.0000174126.28201.61

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

1.  Iron in heart failure: friend or foe?

Authors:  Qurat-ul-ain Jelani; Stuart D Katz
Journal:  Curr Heart Fail Rep       Date:  2010-06

2.  Vascular beneficial effects of polyphenol-rich olive oil and reduced body iron stores.

Authors:  Luca Mascitelli; Mark R Goldstein
Journal:  Eur J Nutr       Date:  2013-12       Impact factor: 5.614

3.  The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores.

Authors:  Ritchard G Cable; Whitney R Steele; Russell S Melmed; Bryce Johnson; Alan E Mast; Patricia M Carey; Joseph E Kiss; Steven H Kleinman; David J Wright
Journal:  Transfusion       Date:  2011-10-20       Impact factor: 3.157

4.  Vascular endothelial function and blood pressure regulation in afferent autonomic failure.

Authors:  Qurat-Ul-Ain Jelani; Lucy Norcliffe-Kaufmann; Horacio Kaufmann; Stuart D Katz
Journal:  Am J Hypertens       Date:  2014-08-15       Impact factor: 2.689

5.  Norepinephrine deficiency with normal blood pressure control in congenital insensitivity to pain with anhidrosis.

Authors:  Lucy Norcliffe-Kaufmann; Stuart D Katz; Felicia Axelrod; Horacio Kaufmann
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

Review 6.  Pathological Roles of Iron in Cardiovascular Disease.

Authors:  Motoi Kobayashi; Tomohiro Suhara; Yuichi Baba; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

7.  Oral contraceptive use, iron stores and vascular endothelial function in healthy women.

Authors:  Julie Friedman; Miriam Cremer; Qurat Ul-Ain Jelani; Xi Huang; Jinlong Jian; Sooraj Shah; Stuart D Katz
Journal:  Contraception       Date:  2011-02-24       Impact factor: 3.375

8.  Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein.

Authors:  Svetlana Krasnokutsky; Aaron Garza Romero; Daisy Bang; Virginia C Pike; Binita Shah; Talia F Igel; Irina Dektiarev; Yu Guo; Judy Zhong; Stuart D Katz; Michael H Pillinger
Journal:  Clin Rheumatol       Date:  2018-02-15       Impact factor: 2.980

9.  The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

Authors:  Leo R Zacharski; Ralph G DePalma; Galina Shamayeva; Bruce K Chow
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

10.  Effects of serial phlebotomy on vascular endothelial function: Results of a prospective double-blind randomized study.

Authors:  Qurat-Ul-Ain Jelani; Bhisham Harchandani; Ritchard G Cable; Yu Guo; Hua Zhong; Timothy Hilbert; Jonathan D Newman; Stuart D Katz
Journal:  Cardiovasc Ther       Date:  2018-11-13       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.